• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染HIV的儿童对麻疹和风疹疫苗的抗体反应。

Antibody response to measles and rubella vaccine by children with HIV infection.

作者信息

Breña A E, Cooper E R, Cabral H J, Pelton S I

机构信息

Department of Pediatrics, Maxwell Finland Laboratory for Infectious Diseases, Boston City Hospital/Boston University School of Medicine, Massachusetts.

出版信息

J Acquir Immune Defic Syndr (1988). 1993 Oct;6(10):1125-9.

PMID:8410669
Abstract

To determine the immunogenicity of the measles and rubella components of the measles, mumps, and rubella virus (MMR) vaccine in human immunodeficiency virus (HIV)-infected children, we compared their response to that of uninfected controls. Sera were collected from HIV-infected patients and HIV seroreverters followed in our clinic and tested as close to 2 months post-MMR vaccination as possible. Specific IgG to both rubella and measles were measured by enzyme-linked immunosorbent assay. Of 20 children with HIV, 11 responded with adequate levels of antibody to measles. In the seroreverters, 12 of 13 responded. Of the measles responders, the median antibody level was significantly lower in the HIV-infected group than in the seroreverter group. In addition, HIV-infected responders tested at 9-15 months after vaccination demonstrated a significant decline in measles antibody levels. Although there was not a difference between the two cohorts in the proportion of patients who responded to the rubella component of the vaccine, there was a significant difference in the median antibody level of the responders of the two groups. We did not find a statistical difference in CD4 counts between responders and nonresponders. Alternate strategies will need to be established to prevent measles in HIV-infected children.

摘要

为了确定麻疹、腮腺炎和风疹病毒(MMR)疫苗中的麻疹和风疹成分对人类免疫缺陷病毒(HIV)感染儿童的免疫原性,我们将他们的反应与未感染的对照组进行了比较。从在我们诊所随访的HIV感染患者和HIV血清转化者中采集血清,并在尽可能接近MMR疫苗接种后2个月时进行检测。通过酶联免疫吸附测定法测量风疹和麻疹的特异性IgG。在20名HIV感染儿童中,11名对麻疹产生了足够水平的抗体反应。在血清转化者中,13名中有12名有反应。在麻疹有反应者中,HIV感染组的抗体水平中位数显著低于血清转化者组。此外,在接种疫苗后9 - 15个月进行检测的HIV感染有反应者显示麻疹抗体水平显著下降。虽然两组在对疫苗风疹成分有反应的患者比例上没有差异,但两组有反应者的抗体水平中位数存在显著差异。我们没有发现有反应者和无反应者之间的CD4细胞计数有统计学差异。需要制定替代策略来预防HIV感染儿童中的麻疹。

相似文献

1
Antibody response to measles and rubella vaccine by children with HIV infection.感染HIV的儿童对麻疹和风疹疫苗的抗体反应。
J Acquir Immune Defic Syndr (1988). 1993 Oct;6(10):1125-9.
2
Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.初次接种麻疹-腮腺炎-风疹疫苗后的抗体持久性以及在4至6岁与11至13岁时接种第二剂疫苗后的反应。
Pediatr Infect Dis J. 1996 Aug;15(8):687-92. doi: 10.1097/00006454-199608000-00010.
3
Response to measles-mumps-rubella vaccine in children on dialysis.透析儿童对麻疹-腮腺炎-风疹疫苗的反应。
Pediatr Nephrol. 1992 Mar;6(2):187-9. doi: 10.1007/BF00866312.
4
Measles, mumps and rubella immunisation in children at risk of infection with human immunodeficiency virus.对有感染人类免疫缺陷病毒风险的儿童进行麻疹、腮腺炎和风疹免疫接种。
J Infect. 1993 Nov;27(3):251-3. doi: 10.1016/0163-4453(93)92010-t.
5
Evaluation of mumps antibodies after measles-mumps-rubella (MMR) vaccines.麻疹-腮腺炎-风疹(MMR)疫苗接种后腮腺炎抗体的评估。
Tokai J Exp Clin Med. 1987 Dec;12(5-6):305-11.
6
[Immunity to measles, mumps and rubella in children vaccinated with triple viral vaccine].接种三联病毒疫苗儿童对麻疹、腮腺炎和风疹的免疫力
Aten Primaria. 1995 Mar 15;15(4):235-7.
7
[Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].[1996年麻疹、腮腺炎和风疹抗体的年龄相关血清流行率]
Schweiz Med Wochenschr. 1998 Apr 25;128(17):649-57.
8
Changes of the immunological patterns against measles, mumps and rubella. A vaccination programme studied 3 to 7 years after the introduction of a two-dose schedule.针对麻疹、腮腺炎和风疹的免疫模式变化。一项在引入两剂次接种方案3至7年后进行研究的疫苗接种计划。
Vaccine. 1991 May;9(5):326-9. doi: 10.1016/0264-410x(91)90058-e.
9
Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination.接种麻疹-腮腺炎-风疹疫苗时患有轻症疾病儿童的抗体反应。
JAMA. 1996 Mar 6;275(9):704-7.
10
Evaluation of live trivalent vaccine of measles AIK-C strain, mumps Hoshino strain and rubella Takahashi strain, by virus-specific interferon-gamma production and antibody response.通过病毒特异性γ干扰素产生和抗体反应评估麻疹AIK-C株、腮腺炎星野株和风疹高桥株的三价活疫苗。
Microbiol Immunol. 1990;34(6):497-508. doi: 10.1111/j.1348-0421.1990.tb03167.x.

引用本文的文献

1
Safety and Immunogenicity of Measles Vaccination in HIV-Infected and HIV-Exposed Uninfected Children: A Systematic Review and Meta-Analysis.感染HIV儿童及暴露于HIV但未感染儿童接种麻疹疫苗的安全性和免疫原性:一项系统评价和荟萃分析
EClinicalMedicine. 2018 Jul 2;1:28-42. doi: 10.1016/j.eclinm.2018.06.002. eCollection 2018 Jul.
2
Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy.接受高效抗逆转录病毒治疗的 HIV 感染儿童麻疹再接种后的免疫原性、免疫记忆和安全性。
J Infect Dis. 2012 Aug 15;206(4):512-22. doi: 10.1093/infdis/jis386. Epub 2012 Jun 12.
3
Measles vaccination: Weighing the benefits and risks of a live viral vaccine for HIV-infected children.
麻疹疫苗接种:权衡针对感染艾滋病毒儿童的活病毒疫苗的利弊
Can J Infect Dis. 1996 Jul;7(4):233-4. doi: 10.1155/1996/943202.
4
Long-term safety and serologic response to measles, mumps, and rubella vaccination in HIV-1 infected adults.HIV-1 感染者中麻疹、腮腺炎和风疹疫苗接种的长期安全性和血清学应答。
Vaccine. 2011 Apr 5;29(16):2874-80. doi: 10.1016/j.vaccine.2011.02.013. Epub 2011 Feb 23.
5
Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination.肯尼亚1型人类免疫缺陷病毒(HIV-1)感染儿童在高效抗逆转录病毒治疗前后及再次接种麻疹和破伤风疫苗后的免疫反应。
Pediatr Infect Dis J. 2009 Apr;28(4):295-9. doi: 10.1097/INF.0b013e3181903ed3.
6
Association of phenotypic changes in B cell lymphocytes and plasma viral load in human immunodeficiency virus-infected patients.人类免疫缺陷病毒感染患者B淋巴细胞表型变化与血浆病毒载量的关联。
J Clin Immunol. 1998 May;18(3):235-40. doi: 10.1023/a:1020539207593.